Unit costs and cost-effectiveness of a device to improve TB treatment adherence in China

BACKGROUND: Adherence to TB drugs is crucial for improving treatment outcomes. Digital adherence technologies can improve adherence; however, there is a lack of evidence on cost-effectiveness. This study aimed to explore the cost-effectiveness of medication event reminder monitors (MERM) in China co...

Full description

Saved in:
Bibliographic Details
Main Authors: S. Sweeney, K. Fielding, X. Liu, J.A. Thompson, H. Dong, S. Jiang, Y. Zhao, S. Huan, A. Vassall
Format: Article
Language:English
Published: International Union Against Tuberculosis and Lung Disease (The Union) 2024-07-01
Series:IJTLD Open
Subjects:
Online Access:https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2024/00000001/00000007/art00004
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832591360903872512
author S. Sweeney
K. Fielding
X. Liu
J.A. Thompson
H. Dong
S. Jiang
Y. Zhao
S. Huan
A. Vassall
author_facet S. Sweeney
K. Fielding
X. Liu
J.A. Thompson
H. Dong
S. Jiang
Y. Zhao
S. Huan
A. Vassall
author_sort S. Sweeney
collection DOAJ
description BACKGROUND: Adherence to TB drugs is crucial for improving treatment outcomes. Digital adherence technologies can improve adherence; however, there is a lack of evidence on cost-effectiveness. This study aimed to explore the cost-effectiveness of medication event reminder monitors (MERM) in China compared with the standard of care, using results from a pragmatic, cluster-randomised superiority trial of an electronic MERM in China. METHODS: We collected primary unit cost data from the societal perspective, both at and above the health facility level. We estimated the incremental cost-effectiveness of MERM using a Markov model with a 20-year time horizon; a 3% discount rate was applied to costs and outcomes. We explored uncertainty through a series of sensitivity and scenario analyses. RESULTS: The incremental cost of MERM was $27.22 per patient. Probabilistic sensitivity analysis showed significant uncertainty about the intervention's cost-effectiveness. Changing assumptions around key parameters substantially affected our estimated incremental cost-effectiveness ratio. CONCLUSIONS: Although the incremental cost of the MERM box was low, current evidence does not indicate that the intervention would be cost-effective. However, the intervention's cost-effectiveness could improve if implemented as part of a broader strategy, including enhanced patient management.
format Article
id doaj-art-302e9ce8f6554d78a1c90e769f920530
institution Kabale University
issn 3005-7590
language English
publishDate 2024-07-01
publisher International Union Against Tuberculosis and Lung Disease (The Union)
record_format Article
series IJTLD Open
spelling doaj-art-302e9ce8f6554d78a1c90e769f9205302025-01-22T12:12:38ZengInternational Union Against Tuberculosis and Lung Disease (The Union)IJTLD Open3005-75902024-07-011729930510.5588/ijtldopen.23.04514Unit costs and cost-effectiveness of a device to improve TB treatment adherence in ChinaS. Sweeney0K. Fielding1X. Liu2J.A. Thompson3H. Dong4S. Jiang5Y. Zhao6S. Huan7A. Vassall8London School of Hygiene & Tropical Medicine, London, UK;London School of Hygiene & Tropical Medicine, London, UK;National Center for TB Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China:London School of Hygiene & Tropical Medicine, London, UK;PATH China Office, Beijing, China;National Center for TB Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China:National Center for TB Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China:Bill & Melinda Gates Foundation China Office, Beijing, ChinaLondon School of Hygiene & Tropical Medicine, London, UK;BACKGROUND: Adherence to TB drugs is crucial for improving treatment outcomes. Digital adherence technologies can improve adherence; however, there is a lack of evidence on cost-effectiveness. This study aimed to explore the cost-effectiveness of medication event reminder monitors (MERM) in China compared with the standard of care, using results from a pragmatic, cluster-randomised superiority trial of an electronic MERM in China. METHODS: We collected primary unit cost data from the societal perspective, both at and above the health facility level. We estimated the incremental cost-effectiveness of MERM using a Markov model with a 20-year time horizon; a 3% discount rate was applied to costs and outcomes. We explored uncertainty through a series of sensitivity and scenario analyses. RESULTS: The incremental cost of MERM was $27.22 per patient. Probabilistic sensitivity analysis showed significant uncertainty about the intervention's cost-effectiveness. Changing assumptions around key parameters substantially affected our estimated incremental cost-effectiveness ratio. CONCLUSIONS: Although the incremental cost of the MERM box was low, current evidence does not indicate that the intervention would be cost-effective. However, the intervention's cost-effectiveness could improve if implemented as part of a broader strategy, including enhanced patient management.https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2024/00000001/00000007/art00004mermchinadigital adherence technologydateconomicstuberculosismedication event reminder monitor
spellingShingle S. Sweeney
K. Fielding
X. Liu
J.A. Thompson
H. Dong
S. Jiang
Y. Zhao
S. Huan
A. Vassall
Unit costs and cost-effectiveness of a device to improve TB treatment adherence in China
IJTLD Open
merm
china
digital adherence technology
dat
economics
tuberculosis
medication event reminder monitor
title Unit costs and cost-effectiveness of a device to improve TB treatment adherence in China
title_full Unit costs and cost-effectiveness of a device to improve TB treatment adherence in China
title_fullStr Unit costs and cost-effectiveness of a device to improve TB treatment adherence in China
title_full_unstemmed Unit costs and cost-effectiveness of a device to improve TB treatment adherence in China
title_short Unit costs and cost-effectiveness of a device to improve TB treatment adherence in China
title_sort unit costs and cost effectiveness of a device to improve tb treatment adherence in china
topic merm
china
digital adherence technology
dat
economics
tuberculosis
medication event reminder monitor
url https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2024/00000001/00000007/art00004
work_keys_str_mv AT ssweeney unitcostsandcosteffectivenessofadevicetoimprovetbtreatmentadherenceinchina
AT kfielding unitcostsandcosteffectivenessofadevicetoimprovetbtreatmentadherenceinchina
AT xliu unitcostsandcosteffectivenessofadevicetoimprovetbtreatmentadherenceinchina
AT jathompson unitcostsandcosteffectivenessofadevicetoimprovetbtreatmentadherenceinchina
AT hdong unitcostsandcosteffectivenessofadevicetoimprovetbtreatmentadherenceinchina
AT sjiang unitcostsandcosteffectivenessofadevicetoimprovetbtreatmentadherenceinchina
AT yzhao unitcostsandcosteffectivenessofadevicetoimprovetbtreatmentadherenceinchina
AT shuan unitcostsandcosteffectivenessofadevicetoimprovetbtreatmentadherenceinchina
AT avassall unitcostsandcosteffectivenessofadevicetoimprovetbtreatmentadherenceinchina